Form 8-K - Current report:
SEC Accession No. 0001104659-14-027425
Filing Date
2014-04-14
Accepted
2014-04-14 08:37:08
Documents
6
Period of Report
2014-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10473_18k.htm 8-K 29633
2 EX-5.1 a14-10473_1ex5d1.htm EX-5.1 13124
3 EX-10.1 a14-10473_1ex10d1.htm EX-10.1 45727
4 EX-99.1 a14-10473_1ex99d1.htm EX-99.1 9778
5 GRAPHIC g104731kii001.jpg GRAPHIC 2445
6 GRAPHIC g104731mmi001.jpg GRAPHIC 4551
  Complete submission text file 0001104659-14-027425.txt   109186
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 14761478
SIC: 2834 Pharmaceutical Preparations